[SYRS] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
15-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -13.53%
YoY- -97.16%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 1,101 317 0 0 0 0 0 -
PBT -11,515 -10,965 -14,169 -12,021 -10,588 -10,689 -8,464 22.75%
Tax 0 0 0 0 0 0 0 -
NP -11,515 -10,965 -14,169 -12,021 -10,588 -10,689 -8,464 22.75%
Tax Rate - - - - - - - -
Total Cost 12,616 11,282 14,169 12,021 10,588 10,689 8,464 30.45%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -1,045.87 -3,458.99 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -4.92 -4.69 -6.44 -47.08 -4.65 -5.96 -33.15 -71.93%
EPS Diluted -4.92 -4.69 -6.44 -47.08 -4.65 -5.96 -33.15 -71.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.